Literature DB >> 3391625

Polymorphism of the 4-hydroxylation of debrisoquine in the San Bushmen of southern Africa.

D K Sommers1, J Moncrieff, J Avenant.   

Abstract

1. The metabolic oxidation of debrisoquine has been studied in a group of 96 San Bushmen. 2. The amounts of debrisoquine and 4-hydroxy-debrisoquine excreted in 0-8 h urine were measured and the metabolic ratio (% dose as debrisoquine/% dose as 4-hydroxy-debrisoquine) calculated. 3. On the basis of Caucasian criteria, that metabolic ratios greater than 12.6 represent poor metabolizers, 19% of the Bushmen were poor metabolizers in contrast to the 8-10% found in Caucasian studies. 4. Probit plots showed four modes may be present in the data, which may represent at least three isozymes of the relevant enzyme which may also differ from the Caucasian isozymes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3391625     DOI: 10.1177/096032718800700308

Source DB:  PubMed          Journal:  Hum Toxicol        ISSN: 0144-5952


  7 in total

1.  Pharmacogenetic comparison of CYP2D6 predictive and measured phenotypes in a South African cohort.

Authors:  T M Dodgen; C De J Labuschagne; A van Schalkwyk; F E Steffens; A Gaedigk; A D Cromarty; M Alessandrini; M S Pepper
Journal:  Pharmacogenomics J       Date:  2015-10-27       Impact factor: 3.550

Review 2.  Pharmacogenetics of antidepressants, mood stabilizers, and antipsychotics in diverse human populations.

Authors:  Eleanor Murphy; Francis J McMahon
Journal:  Discov Med       Date:  2013-09       Impact factor: 2.970

3.  Unimodal distribution of the metabolic ratio for debrisoquine in Cuna Amerindians of Panama.

Authors:  L F Jorge; T D Arias; T Inaba; P R Jackson
Journal:  Br J Clin Pharmacol       Date:  1990-08       Impact factor: 4.335

4.  Oxidative polymorphism of dextromethorphan in a Burundi population.

Authors:  F Nsabiyumva; Y Furet; E Autret; A P Jonville; M Breteau
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

5.  Dextromethorphan O-demethylation polymorphism in Jordanians.

Authors:  Y M Irshaid; H F al-Hadidi; N M Rawashdeh
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

6.  African Genetic Diversity: Implications for Cytochrome P450-mediated Drug Metabolism and Drug Development.

Authors:  Iris Rajman; Laura Knapp; Thomas Morgan; Collen Masimirembwa
Journal:  EBioMedicine       Date:  2017-02-20       Impact factor: 8.143

Review 7.  Revealing the paradox of drug reward in human evolution.

Authors:  Roger J Sullivan; Edward H Hagen; Peter Hammerstein
Journal:  Proc Biol Sci       Date:  2008-06-07       Impact factor: 5.349

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.